Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RY | BAC |
|---|---|---|
| Price | $199.34 | $56.04 |
| Change today | ▼ 0.06% | ▲ 0.06% |
| Market cap | $275.97B | $391.84B |
| Return, 3 months | -0.8% | -2.4% |
| Return, year to date | +19.3% | +3.5% |
| Return, 1 year | +39.1% | +10.7% |
| P/E (TTM) | 17.7 | 12.9 |
| P/B | 2.9 | 1.4 |
| P/E percentile vs own 5y | 95th | 84th |
| Dividend yield | 2.36% | 2.00% |
| Revenue growth (YoY, latest qtr) | +9.1% | +15.0% |
| Net profit growth (YoY) | +11.3% | +26.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 31.2% | 26.9% |
| Return on equity | 17.2% | 11.6% |
| Analyst target vs. price | +12.2% | +22.9% |
| Analyst buy share | 71% | 88% |
| RSI (14) | 43 | 26 |
| 30-day volatility | 17.1% | 23.3% |
| Max drawdown, 1 year | -10.0% | -17.9% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.